Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...

This year's winter surge of influenza and COVID-19 has yet to arrive for most of the country, data published this week by the Centers for Disease Control and Prevention shows, with trends so far a ...

Federal vaccine advisers are reshaping how the United States will approach Covid shots in the coming seasons, shifting from blanket recommendations to a more individualized, risk based strategy. Their ...

Looking for information about the FDA’s limited approval of 2025-26 COVID vaccines? Read what we know about who can get an updated COVID shot this year. Updated Aug. 27 If it feels like several people ...

MPR News guest host Kelly Gordon talked with an infectious disease physician about how the COVID virus is changing, the latest testing guidelines, and how you can best protect yourself and others.

New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...

It's called the XFG variant, but it's better known as "Stratus." That's the name of the latest COVID-19 strain going around. Variant XFG, colloquially known as "Stratus," was first detected in ...

Long COVID definitions vary, complicating diagnosis and treatment, with common symptoms including fatigue, chest pain, and changes in smell. The condition significantly impacts work productivity and ...

The FDA approved 2025-2026 COVID vaccines from Pfizer (Comirnaty), Moderna (Spikevax, mNexspike), and Novavax (Nuvaxovid), the companies announced on Wednesday. But the agency removed one of the ...